US20020049433A1 - Laser treatment of wrinkles - Google Patents
Laser treatment of wrinkles Download PDFInfo
- Publication number
- US20020049433A1 US20020049433A1 US10/010,872 US1087201A US2002049433A1 US 20020049433 A1 US20020049433 A1 US 20020049433A1 US 1087201 A US1087201 A US 1087201A US 2002049433 A1 US2002049433 A1 US 2002049433A1
- Authority
- US
- United States
- Prior art keywords
- dye
- laser light
- pulse
- laser
- msec
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000037303 wrinkles Effects 0.000 title claims abstract description 21
- 238000013532 laser treatment Methods 0.000 title claims description 3
- 206010040954 Skin wrinkling Diseases 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 30
- 210000004204 blood vessel Anatomy 0.000 claims abstract description 13
- 230000036561 sun exposure Effects 0.000 claims abstract description 10
- 230000001678 irradiating effect Effects 0.000 claims abstract description 3
- 238000011282 treatment Methods 0.000 abstract description 5
- 239000000975 dye Substances 0.000 description 151
- 210000004027 cell Anatomy 0.000 description 44
- 230000005284 excitation Effects 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 238000005086 pumping Methods 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 231100000216 vascular lesion Toxicity 0.000 description 6
- 230000003902 lesion Effects 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000001427 coherent effect Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- 208000006787 Port-Wine Stain Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 238000009834 vaporization Methods 0.000 description 3
- 230000008016 vaporization Effects 0.000 description 3
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 206010004950 Birth mark Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010067193 Naevus flammeus Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 208000002026 familial multiple nevi flammei Diseases 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 201000011066 hemangioma Diseases 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 208000000069 hyperpigmentation Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000005372 isotope separation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Images
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01S—DEVICES USING THE PROCESS OF LIGHT AMPLIFICATION BY STIMULATED EMISSION OF RADIATION [LASER] TO AMPLIFY OR GENERATE LIGHT; DEVICES USING STIMULATED EMISSION OF ELECTROMAGNETIC RADIATION IN WAVE RANGES OTHER THAN OPTICAL
- H01S3/00—Lasers, i.e. devices using stimulated emission of electromagnetic radiation in the infrared, visible or ultraviolet wave range
- H01S3/02—Constructional details
- H01S3/022—Constructional details of liquid lasers
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01S—DEVICES USING THE PROCESS OF LIGHT AMPLIFICATION BY STIMULATED EMISSION OF RADIATION [LASER] TO AMPLIFY OR GENERATE LIGHT; DEVICES USING STIMULATED EMISSION OF ELECTROMAGNETIC RADIATION IN WAVE RANGES OTHER THAN OPTICAL
- H01S3/00—Lasers, i.e. devices using stimulated emission of electromagnetic radiation in the infrared, visible or ultraviolet wave range
- H01S3/10—Controlling the intensity, frequency, phase, polarisation or direction of the emitted radiation, e.g. switching, gating, modulating or demodulating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/203—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser applying laser energy to the outside of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00057—Light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
- A61B2018/00476—Hair follicles
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01S—DEVICES USING THE PROCESS OF LIGHT AMPLIFICATION BY STIMULATED EMISSION OF RADIATION [LASER] TO AMPLIFY OR GENERATE LIGHT; DEVICES USING STIMULATED EMISSION OF ELECTROMAGNETIC RADIATION IN WAVE RANGES OTHER THAN OPTICAL
- H01S3/00—Lasers, i.e. devices using stimulated emission of electromagnetic radiation in the infrared, visible or ultraviolet wave range
- H01S3/09—Processes or apparatus for excitation, e.g. pumping
- H01S3/091—Processes or apparatus for excitation, e.g. pumping using optical pumping
- H01S3/0915—Processes or apparatus for excitation, e.g. pumping using optical pumping by incoherent light
- H01S3/092—Processes or apparatus for excitation, e.g. pumping using optical pumping by incoherent light of flash lamp
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01S—DEVICES USING THE PROCESS OF LIGHT AMPLIFICATION BY STIMULATED EMISSION OF RADIATION [LASER] TO AMPLIFY OR GENERATE LIGHT; DEVICES USING STIMULATED EMISSION OF ELECTROMAGNETIC RADIATION IN WAVE RANGES OTHER THAN OPTICAL
- H01S3/00—Lasers, i.e. devices using stimulated emission of electromagnetic radiation in the infrared, visible or ultraviolet wave range
- H01S3/10—Controlling the intensity, frequency, phase, polarisation or direction of the emitted radiation, e.g. switching, gating, modulating or demodulating
- H01S3/13—Stabilisation of laser output parameters, e.g. frequency or amplitude
- H01S3/131—Stabilisation of laser output parameters, e.g. frequency or amplitude by controlling the active medium, e.g. by controlling the processes or apparatus for excitation
- H01S3/1312—Stabilisation of laser output parameters, e.g. frequency or amplitude by controlling the active medium, e.g. by controlling the processes or apparatus for excitation by controlling the optical pumping
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01S—DEVICES USING THE PROCESS OF LIGHT AMPLIFICATION BY STIMULATED EMISSION OF RADIATION [LASER] TO AMPLIFY OR GENERATE LIGHT; DEVICES USING STIMULATED EMISSION OF ELECTROMAGNETIC RADIATION IN WAVE RANGES OTHER THAN OPTICAL
- H01S3/00—Lasers, i.e. devices using stimulated emission of electromagnetic radiation in the infrared, visible or ultraviolet wave range
- H01S3/14—Lasers, i.e. devices using stimulated emission of electromagnetic radiation in the infrared, visible or ultraviolet wave range characterised by the material used as the active medium
- H01S3/20—Liquids
- H01S3/213—Liquids including an organic dye
Definitions
- Vascular lesions comprising enlarged or ectatic blood vessels, pigmented lesions, and tattoos have been successfully treated with lasers for many years.
- the targeted structure, the lesion tissue or tattoo pigment particles, and the surrounding tissue are collectively irradiated with laser light.
- the wavelength or color of this laser light is chosen so that its energy is preferentially absorbed by the target. Localized heating of the target resulting from the preferential absorption leads to its destruction.
- hemoglobin of red blood cells within the ectatic blood vessels serves as the laser light absorber, i.e., the chromophore. These cells absorb the energy of the laser light and transfer this energy to the surrounding vessel as heat. If this occurs quickly and with enough energy, the vessel reaches a temperature to denature the constituents within the boundary of the vessel.
- the fluence Joules per square centimeter, to reach the denaturation of a vessel and the contents is calculated to be that necessary to raise the temperature of the targeted volume within the vessel to about 70° C. before a significant portion of the absorbed laser energy can diffuse out of the vessel.
- the fluence must, however, be limited so that the tissue surrounding the vessel is not also denatured.
- the intensity and pulse duration of the laser light must also be optimized for selectivity by both minimizing diffusion into the surrounding tissue during the pulse while avoiding localized vaporization. Boiling and vaporization lead to mechanical, rather than chemical, damage, which can increase injury and hemorrhage in the tissues that surround the lesion. This constraint suggests that for the fluence necessary to denature the contents of the vessel, the pulse duration should be long and at a low intensity to avoid vaporization. It must also not be too long because of thermal diffusivity. Energy from the laser light pulse must be deposited before heat dissipates into the tissue surrounding the vessel.
- the chromophore is the blood cell hemoglobin within the lesion blood vessels, since the vessels are an order of magnitude larger than the blood cells. Radiation must be added at low intensities so as to not vaporize the small cells, yet long enough to heat the blood vessels by thermal diffusion to the point of denaturation and then terminated before tissue surrounding the blood vessels is damaged.
- flashlamp-excited dye lasers have been used as the laser light source. These lasers have the high spectral brightness required for selective photothermolysis and can be tuned to colors for which preferential absorption occur. For example, colors in the range of 577 to 585 nm match the alpha absorption band of hemoglobin and thus are absorbed well by the red blood cells in the blood vessels. The absorption of melanin, the principal pigment in the skin, is poor in this range, yielding the necessary selectivity.
- the invention of this patent does not generate a light that can be concentrated to the degree obtainable by classic laser configurations. But, the large depth of field and tightly focused beams that coherent radiation provides are not necessary for many medical applications. In treating vascular lesions, focused spots a few millimeters in diameter are adequate. It is often convenient to use fiber optic delivery systems and all that is necessary is to be able to focus the energy from the long pulse dye laser into a fiber approximately one millimeter in diameter.
- Newer devices to treat vascular lesions are once again built according to the typical laser paradigm, i.e. lasers that generate spatially coherent light. It turns out that with optimization, these lasers generate pulse lengths that can equal or exceed those achievable by the design producing spatially incoherent radiation described above. Interestingly, dye choice has a large impact on pulse duration. Reduction in dye degradation by improving longevity through dye chemistry has enabled pulse durations approaching 1.0 msec in commercially available devices.
- the present invention relates generally to method for treating simple wrinkles caused by age or sun exposure by treating blood vessels in the wrinkles with laser light.
- the laser light has a wavelength in a range between 577 and 585 nanometers.
- the laser light may also comprise a laser light pulse with a pulse duration that is greater than 0.2 milliseconds, or in certain embodiments, a pulse duration that is greater than 0.5 milliseconds.
- a dye laser may be employed to generate the laser light.
- a method for treating simple wrinkles caused by age or sun exposure comprises generating a laser light output pulse having a wavelength between 577 and 585 nanometers and delivering the output pulse to the wrinkle-bearing skin of a patient.
- the output pulse may be generated with a dye laser, and may also have a pulse duration that is greater than 0.2 milliseconds, or, in certain embodiments, greater than 0.5 milliseconds.
- a method for treating simple wrinkles caused by age or sun exposure comprises generating a dye laser output pulse and delivering the pulse to the wrinkle-bearing skin of a patient.
- the dye laser output pulse may be generated by exciting dye solution in a resonant cavity with, for instance, one or more flashlamps. Also, the dye may be circulated through the resonant cavity while the pulse is generated.
- the output pulse may have a pulse duration that is greater than 0.2 milliseconds, or, in certain embodiments, greater than 0.5 milliseconds.
- a laser treatment method for simple wrinkles caused by age or sun exposure comprises irradiating wrinkle-bearing skin with a laser light output pulse.
- the pulse duration of the output pulse is selectively matched to the thermal relaxation time of blood vessels in the targeted skin.
- the pulse duration is greater than 0.2 milliseconds. According to some embodiments, the pulse duration exceeds 0.5 milliseconds.
- FIG. 1 schematically shows a selective photothermolysis treatment system of the invention
- FIG. 2 is a schematic perspective view of a first embodiment of the flashlamp-excited pulse dye laser 1 of the present invention
- FIG. 3 is a timing diagram showing the relationship between the trigger signal from the controller 160 , the flashlamp driving current, and the laser pulse amplitude for one pulse of the dye laser 1 ;
- FIG. 4 is a circuit diagram of the flashlamp driver 162 of the present invention.
- FIGS. 5A and 5B show the differences between longitudinal and transverse dye flow, respectively, through the resonant cavity of a laser
- FIG. 6 schematically shows a dye cell 105 configured for longitudinal dye flow through the dye cell
- FIG. 7 schematically shows a dye cell 105 configured for longitudinal dye flow and having multiple input 610 - 614 and output ports 620 - 624 to reduce the residence time of dye solution in the dye cell 105 .
- FIG. 1 shows a selective photothermolysis treatment system 10 , which has been constructed according to the principles of the present invention.
- a flashlamp-excited pulse dye laser 1 for the system 10 generates an output laser light pulse 120 .
- the output laser light pulse 120 is coupled into a medical delivery system 20 , such as a single optical fiber, and transported to the skin 50 or other tissue of a patient.
- the output laser light pulse 120 achieves substantial penetration to treat a vascular lesion 60 .
- This lesion 60 could be of one of many different types such as portwine stain birthmarks, hemangiomas, telangiectasia, idiopathic vulvoddynia, and leg veins. Further, it could also be vessels in simple wrinkles, caused by age or sun exposure, blood vessels in scar tissue, or hair follicles.
- the pulse durations of the output laser light pulse 120 are matched to the thermal relaxation time of the targeted ectatic vessels. Generally, this requires durations greater than 0.2 msec. For vessels of 30 microns in diameter and larger, as are present in portwine stains of adult patients, the duration should ideally exceed 0.5 msec, whereas pulse durations of 1 msec to 10 msec should be selected when the vessels are larger than 100 microns.
- FIG. 2 is a schematic diagram illustrating the flashlamp-excited pulse dye laser 1 in more detail.
- a dye cell 105 for containing a liquid laser gain media specifically a dye solution, extends longitudinally along a center axis 108 of the laser 1 .
- a front window 130 and a rear window 132 define the longitudinal extents of the dye cell 105 . Both windows 130 and 132 are transparent.
- the dye cell 105 is located in a resonant cavity 110 , the ends of which are defined by a first mirror 112 and a second mirror 114 .
- the cavity does not support only single longitudinal mode or single frequency. While the second mirror 114 is fully reflective, the first mirror 112 is partially reflective and partially transmissive, defining an output aperture 116 . As a result, a portion of the light generated in the resonant cavity 110 passes through this first mirror 112 as the output beam 120 of the laser 1 .
- the dye solution in the dye cell 105 is optically pumped by flashlamps 124 a and 124 b .
- Exterior to a light-transmissive left side wall 122 a of the dye cell 105 is a left flashlamp 124 b .
- a right flashlamp 124 a is on an exterior side of a right side wall 122 b, which is also transmissive to light.
- These flashlamps 124 a , 124 b generate broadband light that excites the dye solution contained in the dye cell 105 . This results in the stimulated emission of light from the excited dye solution.
- Right and left reflectors 126 a and 126 b surround the respective flashlamps 124 a and 124 b to maximize the light injected into the dye cell 105 .
- the flashlamps 124 a and 124 b used in the present invention preferably have higher pulse energies than typically found in short pulse dye lasers. During the generation of an output laser light pulse of 5 msecs, the total pumping energy injected into the dye solution by the flashlamps is approximately 2000 Joules.
- a dye circulator functions to circulate dye solution through the dye cell 105 while that dye solution is being excited by the flashlamps 124 a , 124 b .
- This operation enables a flashlamp-excited pulse dye laser 1 to extend the duration of the output laser light pulse 120 beyond that would be obtainable in a dye laser in which the degraded dye was not replaced during the laser pulse.
- the degradation of the dye during the output laser light pulse would quench the lasing action within usually about 0.5 msec.
- this circulator includes a dye pump 150 which receives new dye solution from a supply reservoir 152 .
- the dye is pumped into a supply manifold 154 (shown here in phantom), which distributes the dye solution flow along the longitudinal axis 108 of the dye laser 1 .
- the dye solution flows through the dye cell 105 , and thus the resonant cavity 110 , in a direction transverse to the axis 108 of the laser 1 .
- a collection manifold 156 (in phantom) collects the dye solution after it has passed through the dye cell 105 and directs it to a depleted dye reservoir 158 .
- a separate supply reservoir 152 and depleted dye reservoir 158 are not strictly necessary. Recirculation and filtration systems are possible.
- a controller 160 coordinates the operation of the dye pump 150 and the triggering of the flashlamps 124 a and 124 b to achieve extended pulse durations of the output laser light 120 by replacing exhausted dye solution in the dye cell 105 during the laser pulses. Specifically, the controller 160 first establishes a steady state flow of dye solution through the dye cell 105 by activating the dye pump 150 . When the dye solution is flowing through the dye cell 105 , the controller 160 then sends a trigger signal to a flashlamp driver 162 . The trigger signal defines the pulse durations and causes the flashlamp driver 162 to supply a driving current to the flashlamps 124 a and 124 b . Light from the flashlamps excites the dye solution to lase and produce the output laser light 120 .
- Constant amplitude output laser light pulse are produced with an intensity detector 164 that senses the intensity of the output laser light 120 and provides feedback to the flashlamp driver 162 .
- the detector can be a diode or other photodetector that generates an intensity signal indicative of the amplitude of the output laser light.
- This signal is received by the flashlamp driver 162 .
- the feedback signal is combined with the trigger signal. This allows the flashlamp driver to adaptively modify the level of the driving current to the flashlamps 124 a , 124 b in response to the instantaneous intensity of the output laser light. If the gain medium contains depleted dye, an increase in excitation is required to maintain constant output.
- the excitation pulse will remain nearly constant.
- some exhausted dye solution tends to accumulate in the dye cell 105 over the course of the pulse.
- the percentage of new, unexhausted, dye is never as large as the moment before the flashlamps are first driven.
- At least some of the light generated in the dye cell 105 is absorbed by this exhausted dye solution and this effect tends to increase the threshold level of excitation needed for lasing.
- the intensity detector 164 detects any reduction in output light amplitude and causes the flashlamp to be driven harder to maintain constant output levels.
- the driving current is varied to maintain a constant amplitude in the output light amplitude.
- ramp trigger pulse can be used to generate an increasing or decreasing intensity in the output laser light, which is optimal for some applications.
- the speed at which the dye is replaced in the dye cell 105 is dependent upon the how quickly the dye degrades. If the dye is exhausted after 2.5 msec, it must be replaced within that time. The total number of times that the dye is replaced in the dye cell 105 depends upon the required pulse duration. For example, a pulse duration of 10 msec, requires the equivalent of at least four dye replacements with dye lifetimes of 2.5 msec.
- Photothermolysis treatment of larger ectatic vessels require the longer pulse durations obtainable by the present invention.
- Vessels of 100 and 200 micrometers in diameter have thermal relaxation times of 4.8 and 19.0 msec, respectively, and require similar pulse durations for optimally effective therapy.
- energies are usually from 1 to 20 Joules, but fifty Joules can be required in hair removal applications.
- FIG. 3 shows trigger signal voltage, the flashlamp excitation in Amperes, and the laser pulse amplitude 120 as a function of time during the pulse generation.
- the controller 160 first engages the dye pump 150 to establish steady state dye flow through the dye cell 105 prior to the beginning of the laser pulse.
- the controller 160 then sends the trigger signal to the flashlamp driver 162 .
- the length of this trigger signal defines the desired duration of the output laser light pulse 120 . In the example shown, the duration is 5 milliseconds plus the latency time T that is required to excite the dye solution to lase.
- the flashlamp driver 162 Prior to the trigger signal, the flashlamp driver 162 maintains a slightly sub-operational current in the flashlamps 124 a and 124 b with a simmer current 205 as is conventional. Then, in response to the leading edge 206 of the trigger signal, the flashlamp driver 162 produces a driving current for the flashlamps 124 a and 124 b .
- the flashlamps functioning as the laser-pumping devices, pump the dye solution in the dye cell 105 into an excited state causing it to lase when the fresh dye lasing threshold 208 is reached. This causes the output laser light pulse 120 having an amplitude indicated by reference numeral 212 .
- the flashlamp driver 162 increases the current to the flashlamps 124 a and 124 b over the duration of the output laser pulse in response the feedback signal from the intensity detector 164 .
- Progressively more driving current is required due to the accumulation of degraded dye solution in the cell 105 which yields an increasing lasing threshold 209 .
- an equilibrium in the ratio of degraded dye to fresh dye is reached and the lasing threshold plateaues 211 .
- the excitation current is also steady state 210 .
- the resulting laser output 212 begins as the flashlamp power rises above the threshold level 208 , time T after the rising edge of the trigger signal 206 .
- the pulse terminates after five millisecond when the falling edge 215 of the trigger signal is generated by the controller 160 .
- FIG. 4 is a circuit diagram of the flashlamp driver 162 shown in FIG. 2 that actively controls the level of driving of the flashlamps in response to the intensity of the generated laser light.
- the flashlamp driver 162 receives the trigger signal from the controller 160 via conductor 305 .
- This trigger signal defines the time for which the flashlamps will be driven and thus the duration of the laser light pulse.
- the length of the laser light pulse is tunable by changing the length of the trigger signal.
- This signal is received at a summing node 310 through a resistor R 1 .
- the feedback signal which is indicative of the intensity of the output laser light 120 , is received from the intensity detector 164 through a resistor R 2 also at the summing node 310 .
- the voltage of the summing node is biased by third resistor R 3 that is connected between the summing node 310 and the supply voltage Vcc.
- the trigger signal is a low level active signal which pulls the voltage of the summing node 310 below ground.
- a comparator 315 compares the voltage of the summing node to the ground potential.
- the comparator 315 turns a power transistor such as an insulated gate breakdown transistor (IGBT) or power Darlington 320 on, rendering the transistor conductive. This event places the voltage of a high voltage power supply 325 across the flashlamp, which generates a driving current to the flashlamps 124 a and 124 b .
- IGBT insulated gate breakdown transistor
- a capacitor C 1 stores charge to assist in driving the flashlamps 124 a , 124 b .
- a simmer supply 340 is also connected across the flashlamps 124 a and 124 b to provide a simmer current to maintain a stable voltage across the lamp prior to the main excitation pulse. Without the simmer, operation is erratic. This simmer current is evident from portion 205 of the flashlamp excitation plot in FIG. 3.
- the applicability of the flashlamp driver 162 is not limited to flashlamp-excited dye lasers with dye circulators but can be implemented as the driver for pumping devices that excite the gain media in many other types of lasers. Many types of lasers suffer from an increased excitation threshold across the length of a light pulse. Characteristically, conventional flashlamp-excited dye lasers, without dye flow suffer from this problem. This inventive pumping device driver 162 also find applicability to these lasers and also laser-excited dye lasers. In those cases, the flashlamp or other type of laser-pumping device will supply an ever increasing excitation current in response to any loss of intensity at the laser output.
- FIGS. 5A and 5B illustrate the key differences between a longitudinal flow dye laser and the transverse flow configuration.
- the first embodiment of FIG. 1 corresponds to the transverse flow type of FIG. 5B.
- These configurations generally provide shorter residence time of the dye solution in the dye cell 105 .
- the dye solution must merely move across the width of the resonant cavity 110 .
- the longitudinal flow configuration of FIG. 5A offers an alternative. But, since the dye solution moves along the length of the dye cell, resident time is longer for the same flow velocity.
- FIG. 6 illustrates a second embodiment of the dye cell 505 in which the dye solution travels longitudinally along the length of the dye cell 505 , parallel to the laser axis 530 .
- the dye solution is circulated through an input port 510 by a pump 150 .
- the dye travels the length 1 of the dye cell 505 and exits an output port 515 .
- First and second mirrors 112 , 114 define the resonant cavity 520 in which the dye cell 505 is located as described in connection with FIG. 1.
- the second embodiment configuration places certain limits on the dye cell 505 construction.
- a given cross-section of fluid 550 should traverse the length of the dye cell 505 in approximately 2.5 msec. This is a good estimate for the useable lifetime of dye solutions during lasing. But, velocity is limited by the pressure the dye cell 505 can withstand.
- a rule of thumb is that a flow of 10 meters per second is the maximum speed for pumps operating below 100 pound per square inch (psi). These factors limit the length of the dye cell 505 to approximately one inch in length.
- FIG. 7 shows a third embodiment based upon a modification of the second embodiment of FIG. 6.
- a plurality of dye input ports 610 , 612 , 614 are placed longitudinally along the length of dye cell 605 .
- An input manifold 625 of the circulator supplies dye to each of these ports from a pump 650 .
- Output ports 620 , 622 , 624 are placed between the input ports 610 - 614 on the opposite side of the dye cell 105 .
- An output manifold 632 collects dye solution exiting the dye cell 605 through these ports.
- dye flowing through any one of the input ports 610 - 614 is divided and passes out both of the nearest output ports 620 - 624 , again flowing parallel to the laser axis 630 . If the longitudinal distance between an input port and the closest output port is approximately 25 mm, 50 mm between adjacent input ports, a flow velocity of 10 m/sec is sufficient to limit the residence time of the dye solution to 2.5 msec. This allows the dye solution to be interchanged twice in a 5 msec laser pulse duration or four times in a 10 msec pulse.
- Dye Lasers having a transverse flow of dye gain media through the resonant cavity have been developed in the past in a number of different contexts for different applications.
- Continuous wave (cw) dye lasers have even been developed.
- the dye in these lasers is pumped by another laser. This laser is focused on a small spot on a curtain of the flowing dye solution.
- volume of dye excited in this device is very small. Only the small portion of the dye curtain in the path of the beam from the focused pumping laser is excited, and therefore generates light by stimulated emission.
- this type of laser-excited dye laser generates a continuous wave output, it can not produce the kilowatts of peak power with the energy content required by medical applications.
- Very high pulse rate transverse flow dye lasers have been developed for isotope separation applications. The intent of these designs is to produce output energies of approximately one Joule in a few microseconds. Thermal distortion, which limited firing rates were avoided by replacing the excited dye in the resonant cavity from a previous pulse with new dye and then triggering the flashlamp. Such devices have been shown to generate pulse frequencies of almost one kilohertz. In these industrial applications, the peak and average output powers and pulse frequencies far exceed those required for medical procedures where longer pulse durations, moderate peak and average powers at lower frequencies are preferred. Average power close to a kilowatt have been generated using transverse flow dye lasers. For medical application, average power of only a few Watts is required.
Abstract
A method for treating simple wrinkles caused by age or sun exposure comprises treating blood vessels in the wrinkles with laser light. The laser light may have a wavelength between 577 and 585 nm. The laser light may also be a laser light pulse having a pulse duration that is greater than 0.2 msec, or alternatively, greater than 0.5 msec. The output pulse may be generated with a dye laser, for instance, by exciting dye solution in a resonant cavity with one or more flashlamps. A further treatment method comprises irradiating wrinkle-bearing skin with a laser pulse where the pulse duration is selectively matched to the thermal relaxation time of blood vessels in the targeted skin.
Description
- This application is a continuation of application Ser. No. 09/797,124, filed Mar. 1, 2001, which is a continuation of application Ser. No. 08/822,448, filed Mar. 21, 1997, now abandoned, which is a division of application Ser. No. 08/461,952, filed Jun. 5, 1995, and now U.S. Pat. No. 5,624,435. The entire teachings of the above applications are incorporated herein by reference.
- Vascular lesions, comprising enlarged or ectatic blood vessels, pigmented lesions, and tattoos have been successfully treated with lasers for many years. In the process called selective photothermolysis, the targeted structure, the lesion tissue or tattoo pigment particles, and the surrounding tissue are collectively irradiated with laser light. The wavelength or color of this laser light, however, is chosen so that its energy is preferentially absorbed by the target. Localized heating of the target resulting from the preferential absorption leads to its destruction.
- Most commonly in the context of vascular lesions, such as portwine stains for example, hemoglobin of red blood cells within the ectatic blood vessels serves as the laser light absorber, i.e., the chromophore. These cells absorb the energy of the laser light and transfer this energy to the surrounding vessel as heat. If this occurs quickly and with enough energy, the vessel reaches a temperature to denature the constituents within the boundary of the vessel. The fluence, Joules per square centimeter, to reach the denaturation of a vessel and the contents is calculated to be that necessary to raise the temperature of the targeted volume within the vessel to about 70° C. before a significant portion of the absorbed laser energy can diffuse out of the vessel. The fluence must, however, be limited so that the tissue surrounding the vessel is not also denatured.
- As suggested, simply selecting the necessary fluence is not enough. The intensity and pulse duration of the laser light must also be optimized for selectivity by both minimizing diffusion into the surrounding tissue during the pulse while avoiding localized vaporization. Boiling and vaporization lead to mechanical, rather than chemical, damage, which can increase injury and hemorrhage in the tissues that surround the lesion. This constraint suggests that for the fluence necessary to denature the contents of the vessel, the pulse duration should be long and at a low intensity to avoid vaporization. It must also not be too long because of thermal diffusivity. Energy from the laser light pulse must be deposited before heat dissipates into the tissue surrounding the vessel. The situation becomes more complex if the chromophore is the blood cell hemoglobin within the lesion blood vessels, since the vessels are an order of magnitude larger than the blood cells. Radiation must be added at low intensities so as to not vaporize the small cells, yet long enough to heat the blood vessels by thermal diffusion to the point of denaturation and then terminated before tissue surrounding the blood vessels is damaged.
- Conventionally, flashlamp-excited dye lasers have been used as the laser light source. These lasers have the high spectral brightness required for selective photothermolysis and can be tuned to colors for which preferential absorption occur. For example, colors in the range of 577 to 585 nm match the alpha absorption band of hemoglobin and thus are absorbed well by the red blood cells in the blood vessels. The absorption of melanin, the principal pigment in the skin, is poor in this range, yielding the necessary selectivity.
- The implementation of flashlamp-excited dye lasers presents problems in the pulse length obtainable by this type of laser. Theory dictates that the length of the light pulse should be on the order of the thermal relaxation time of the ectatic vessels. Ectatic vessels of greater than 30 microns in diameter are characteristic of cutaneous vascular lesions. These large vessel have relaxation times of 0.5 msec and require pulse durations of this length. Commercially available flashlamp-excited dye lasers generally have maximum pulse lengths that are shorter than 0.5 msec. As a result, selective photothermolysis treatment of ectatic vessels larger than 30 microns currently relies on higher than optimum irradiance to compensate for the pulse duration limitations. This leads to temporary hyperpigmentation, viz., purpura.
- Attempts have been made to increase the pulse durations of flashlamp-excited dye lasers. The Light Amplifier disclosed in U.S. Pat. Nos. 4,829,262 and 5,066,293 was conceived by the present inventor to mitigate laser quenching from thermal effects. The design centered on developing a spatially non-coherent laser. Basically, the optics at each end of the dye cell are designed to return substantially all of the light emanating from the end aperture back through the dye cell and reflect off the dye cell walls. Specific resonating and coherent modes are not favored. The optics mix the rays and thoroughly homogenize the beam. Thus, the effects from thermal distortions induced by the flashlamp are mitigated since resonator modes are not required for lasing action to occur. The invention of this patent does not generate a light that can be concentrated to the degree obtainable by classic laser configurations. But, the large depth of field and tightly focused beams that coherent radiation provides are not necessary for many medical applications. In treating vascular lesions, focused spots a few millimeters in diameter are adequate. It is often convenient to use fiber optic delivery systems and all that is necessary is to be able to focus the energy from the long pulse dye laser into a fiber approximately one millimeter in diameter.
- Newer devices to treat vascular lesions are once again built according to the typical laser paradigm, i.e. lasers that generate spatially coherent light. It turns out that with optimization, these lasers generate pulse lengths that can equal or exceed those achievable by the design producing spatially incoherent radiation described above. Interestingly, dye choice has a large impact on pulse duration. Reduction in dye degradation by improving longevity through dye chemistry has enabled pulse durations approaching 1.0 msec in commercially available devices.
- The present invention relates generally to method for treating simple wrinkles caused by age or sun exposure by treating blood vessels in the wrinkles with laser light. In specific embodiments, the laser light has a wavelength in a range between 577 and 585 nanometers. The laser light may also comprise a laser light pulse with a pulse duration that is greater than 0.2 milliseconds, or in certain embodiments, a pulse duration that is greater than 0.5 milliseconds. A dye laser may be employed to generate the laser light.
- According to one aspect, a method for treating simple wrinkles caused by age or sun exposure comprises generating a laser light output pulse having a wavelength between 577 and 585 nanometers and delivering the output pulse to the wrinkle-bearing skin of a patient. The output pulse may be generated with a dye laser, and may also have a pulse duration that is greater than 0.2 milliseconds, or, in certain embodiments, greater than 0.5 milliseconds.
- According to another aspect, a method for treating simple wrinkles caused by age or sun exposure comprises generating a dye laser output pulse and delivering the pulse to the wrinkle-bearing skin of a patient. The dye laser output pulse may be generated by exciting dye solution in a resonant cavity with, for instance, one or more flashlamps. Also, the dye may be circulated through the resonant cavity while the pulse is generated. The output pulse may have a pulse duration that is greater than 0.2 milliseconds, or, in certain embodiments, greater than 0.5 milliseconds.
- According to yet another aspect, a laser treatment method for simple wrinkles caused by age or sun exposure comprises irradiating wrinkle-bearing skin with a laser light output pulse. In this embodiment, the pulse duration of the output pulse is selectively matched to the thermal relaxation time of blood vessels in the targeted skin. In certain embodiments, the pulse duration is greater than 0.2 milliseconds. According to some embodiments, the pulse duration exceeds 0.5 milliseconds.
- The above and other features of the invention including various novel details of construction and combinations of parts, and other advantages, will now be more particularly described with reference to the accompanying drawings and pointed out in the claims. It will be understood that the particular method and device embodying the invention is shown by way of illustration and not as a limitation of the invention. The principles and features of this invention may be employed in various and numerous embodiments without the departing from the scope of the invention.
- FIG. 1 schematically shows a selective photothermolysis treatment system of the invention;
- FIG. 2 is a schematic perspective view of a first embodiment of the flashlamp-excited pulse dye laser1 of the present invention;
- FIG. 3 is a timing diagram showing the relationship between the trigger signal from the
controller 160, the flashlamp driving current, and the laser pulse amplitude for one pulse of the dye laser 1; - FIG. 4 is a circuit diagram of the
flashlamp driver 162 of the present invention; - FIGS. 5A and 5B show the differences between longitudinal and transverse dye flow, respectively, through the resonant cavity of a laser;
- FIG. 6 schematically shows a
dye cell 105 configured for longitudinal dye flow through the dye cell; and - FIG. 7 schematically shows a
dye cell 105 configured for longitudinal dye flow and having multiple input 610-614 and output ports 620-624 to reduce the residence time of dye solution in thedye cell 105. - The foregoing and other objects, features and advantages of the invention will be apparent from the following more particular description of preferred embodiments of the invention, as illustrated in the accompanying drawings in which like reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention.
- A description of preferred embodiments of the invention follows.
- Turning now to the drawings, FIG. 1 shows a selective
photothermolysis treatment system 10, which has been constructed according to the principles of the present invention. A flashlamp-excited pulse dye laser 1 for thesystem 10 generates an output laserlight pulse 120. The output laserlight pulse 120 is coupled into amedical delivery system 20, such as a single optical fiber, and transported to theskin 50 or other tissue of a patient. The output laserlight pulse 120 achieves substantial penetration to treat avascular lesion 60. Thislesion 60 could be of one of many different types such as portwine stain birthmarks, hemangiomas, telangiectasia, idiopathic vulvoddynia, and leg veins. Further, it could also be vessels in simple wrinkles, caused by age or sun exposure, blood vessels in scar tissue, or hair follicles. - The pulse durations of the output laser
light pulse 120 are matched to the thermal relaxation time of the targeted ectatic vessels. Generally, this requires durations greater than 0.2 msec. For vessels of 30 microns in diameter and larger, as are present in portwine stains of adult patients, the duration should ideally exceed 0.5 msec, whereas pulse durations of 1 msec to 10 msec should be selected when the vessels are larger than 100 microns. - FIG. 2 is a schematic diagram illustrating the flashlamp-excited pulse dye laser1 in more detail. As is generally common among most such lasers, a
dye cell 105 for containing a liquid laser gain media, specifically a dye solution, extends longitudinally along acenter axis 108 of the laser 1. Afront window 130 and arear window 132 define the longitudinal extents of thedye cell 105. Bothwindows dye cell 105 is located in aresonant cavity 110, the ends of which are defined by afirst mirror 112 and asecond mirror 114. - Usually, the cavity does not support only single longitudinal mode or single frequency. While the
second mirror 114 is fully reflective, thefirst mirror 112 is partially reflective and partially transmissive, defining anoutput aperture 116. As a result, a portion of the light generated in theresonant cavity 110 passes through thisfirst mirror 112 as theoutput beam 120 of the laser 1. - The dye solution in the
dye cell 105 is optically pumped byflashlamps left side wall 122 a of thedye cell 105 is aleft flashlamp 124 b. Aright flashlamp 124 a is on an exterior side of a right side wall 122 b, which is also transmissive to light. Theseflashlamps dye cell 105. This results in the stimulated emission of light from the excited dye solution. Right and leftreflectors respective flashlamps dye cell 105. These reflectors can be elliptical or diffuse. According to the invention, theflashlamps - A dye circulator functions to circulate dye solution through the
dye cell 105 while that dye solution is being excited by theflashlamps light pulse 120 beyond that would be obtainable in a dye laser in which the degraded dye was not replaced during the laser pulse. For example, in a conventional laser, the degradation of the dye during the output laser light pulse would quench the lasing action within usually about 0.5 msec. In the present invention, the duration of the output laserlight pulse 120 is increased beyond this quench time of the conventional laser by essentially injecting new dye into the resonant cavity to replace degraded dye that absorbs laser light and quench laser action and thus increase the pulses duration. In the embodiment shown, this circulator includes adye pump 150 which receives new dye solution from asupply reservoir 152. The dye is pumped into a supply manifold 154 (shown here in phantom), which distributes the dye solution flow along thelongitudinal axis 108 of the dye laser 1. The dye solution flows through thedye cell 105, and thus theresonant cavity 110, in a direction transverse to theaxis 108 of the laser 1. A collection manifold 156 (in phantom) collects the dye solution after it has passed through thedye cell 105 and directs it to a depleteddye reservoir 158. - A
separate supply reservoir 152 and depleteddye reservoir 158 are not strictly necessary. Recirculation and filtration systems are possible. U.S. patent application Ser. No. 08/165,331, filed on Dec. 10, 1993, entitled Method and Apparatus for Replenishing Dye Solution in a Dye Laser, now U.S. Pat. No. 5,668,824, which is incorporated herein by this reference, is directed a system in which by-products from the lasing process are filtered out and the dye solution reused. - A
controller 160 coordinates the operation of thedye pump 150 and the triggering of theflashlamps output laser light 120 by replacing exhausted dye solution in thedye cell 105 during the laser pulses. Specifically, thecontroller 160 first establishes a steady state flow of dye solution through thedye cell 105 by activating thedye pump 150. When the dye solution is flowing through thedye cell 105, thecontroller 160 then sends a trigger signal to aflashlamp driver 162. The trigger signal defines the pulse durations and causes theflashlamp driver 162 to supply a driving current to theflashlamps output laser light 120. - Constant amplitude output laser light pulse are produced with an
intensity detector 164 that senses the intensity of theoutput laser light 120 and provides feedback to theflashlamp driver 162. Typically, the detector can be a diode or other photodetector that generates an intensity signal indicative of the amplitude of the output laser light. This signal is received by theflashlamp driver 162. There, the feedback signal is combined with the trigger signal. This allows the flashlamp driver to adaptively modify the level of the driving current to theflashlamps dye cell 105 over the course of the pulse. In fact, even with fast circulation, the percentage of new, unexhausted, dye is never as large as the moment before the flashlamps are first driven. At least some of the light generated in thedye cell 105 is absorbed by this exhausted dye solution and this effect tends to increase the threshold level of excitation needed for lasing. Theintensity detector 164 detects any reduction in output light amplitude and causes the flashlamp to be driven harder to maintain constant output levels. Thus, the driving current is varied to maintain a constant amplitude in the output light amplitude. Alternatively, ramp trigger pulse can be used to generate an increasing or decreasing intensity in the output laser light, which is optimal for some applications. - Longer pulse durations are possible by circulating dye solution through the dye cell during the generation of the output laser light pulse while providing very intense exciting energies from the
flashlamps dye cell 105 at least twice during the pulse. As a result, as the dye solution becomes partially or completely exhausted, new solution is added to thecell 105 to replace the old solution, which is pumped out by the circulator. In the present invention, the speed at which the dye is replaced in thedye cell 105 is dependent upon the how quickly the dye degrades. If the dye is exhausted after 2.5 msec, it must be replaced within that time. The total number of times that the dye is replaced in thedye cell 105 depends upon the required pulse duration. For example, a pulse duration of 10 msec, requires the equivalent of at least four dye replacements with dye lifetimes of 2.5 msec. - Photothermolysis treatment of larger ectatic vessels, for example, require the longer pulse durations obtainable by the present invention. Vessels of 100 and 200 micrometers in diameter have thermal relaxation times of 4.8 and 19.0 msec, respectively, and require similar pulse durations for optimally effective therapy. Energies are usually from 1 to 20 Joules, but fifty Joules can be required in hair removal applications.
- FIG. 3 shows trigger signal voltage, the flashlamp excitation in Amperes, and the
laser pulse amplitude 120 as a function of time during the pulse generation. Specifically, thecontroller 160 first engages thedye pump 150 to establish steady state dye flow through thedye cell 105 prior to the beginning of the laser pulse. Thecontroller 160 then sends the trigger signal to theflashlamp driver 162. The length of this trigger signal defines the desired duration of the output laserlight pulse 120. In the example shown, the duration is 5 milliseconds plus the latency time T that is required to excite the dye solution to lase. - Prior to the trigger signal, the
flashlamp driver 162 maintains a slightly sub-operational current in theflashlamps leading edge 206 of the trigger signal, theflashlamp driver 162 produces a driving current for theflashlamps dye cell 105 into an excited state causing it to lase when the freshdye lasing threshold 208 is reached. This causes the output laserlight pulse 120 having an amplitude indicated byreference numeral 212. Generally, theflashlamp driver 162 increases the current to theflashlamps intensity detector 164. Progressively more driving current is required due to the accumulation of degraded dye solution in thecell 105 which yields an increasinglasing threshold 209. As some point, an equilibrium in the ratio of degraded dye to fresh dye is reached and thelasing threshold plateaues 211. Now, the excitation current is alsosteady state 210. - The resulting
laser output 212 begins as the flashlamp power rises above thethreshold level 208, time T after the rising edge of thetrigger signal 206. The pulse terminates after five millisecond when the fallingedge 215 of the trigger signal is generated by thecontroller 160. - FIG. 4 is a circuit diagram of the
flashlamp driver 162 shown in FIG. 2 that actively controls the level of driving of the flashlamps in response to the intensity of the generated laser light. Specifically, theflashlamp driver 162 receives the trigger signal from thecontroller 160 viaconductor 305. This trigger signal defines the time for which the flashlamps will be driven and thus the duration of the laser light pulse. The length of the laser light pulse is tunable by changing the length of the trigger signal. This signal is received at a summingnode 310 through a resistor R1. The feedback signal, which is indicative of the intensity of theoutput laser light 120, is received from theintensity detector 164 through a resistor R2 also at the summingnode 310. The voltage of the summing node is biased by third resistor R3 that is connected between the summingnode 310 and the supply voltage Vcc. In the particular embodiment shown, the trigger signal is a low level active signal which pulls the voltage of the summingnode 310 below ground. Acomparator 315 compares the voltage of the summing node to the ground potential. Thus, in response to a receipt of the trigger signal thecomparator 315 turns a power transistor such as an insulated gate breakdown transistor (IGBT) orpower Darlington 320 on, rendering the transistor conductive. This event places the voltage of a high voltage power supply 325 across the flashlamp, which generates a driving current to theflashlamps flashlamps simmer supply 340 is also connected across theflashlamps portion 205 of the flashlamp excitation plot in FIG. 3. - The applicability of the
flashlamp driver 162 is not limited to flashlamp-excited dye lasers with dye circulators but can be implemented as the driver for pumping devices that excite the gain media in many other types of lasers. Many types of lasers suffer from an increased excitation threshold across the length of a light pulse. Characteristically, conventional flashlamp-excited dye lasers, without dye flow suffer from this problem. This inventivepumping device driver 162 also find applicability to these lasers and also laser-excited dye lasers. In those cases, the flashlamp or other type of laser-pumping device will supply an ever increasing excitation current in response to any loss of intensity at the laser output. - FIGS. 5A and 5B illustrate the key differences between a longitudinal flow dye laser and the transverse flow configuration. The first embodiment of FIG. 1 corresponds to the transverse flow type of FIG. 5B. These configurations generally provide shorter residence time of the dye solution in the
dye cell 105. The dye solution must merely move across the width of theresonant cavity 110. The longitudinal flow configuration of FIG. 5A offers an alternative. But, since the dye solution moves along the length of the dye cell, resident time is longer for the same flow velocity. - FIG. 6 illustrates a second embodiment of the
dye cell 505 in which the dye solution travels longitudinally along the length of thedye cell 505, parallel to thelaser axis 530. The dye solution is circulated through aninput port 510 by apump 150. The dye travels the length 1 of thedye cell 505 and exits anoutput port 515. First andsecond mirrors resonant cavity 520 in which thedye cell 505 is located as described in connection with FIG. 1. - The second embodiment configuration places certain limits on the
dye cell 505 construction. A given cross-section offluid 550 should traverse the length of thedye cell 505 in approximately 2.5 msec. This is a good estimate for the useable lifetime of dye solutions during lasing. But, velocity is limited by the pressure thedye cell 505 can withstand. A rule of thumb is that a flow of 10 meters per second is the maximum speed for pumps operating below 100 pound per square inch (psi). These factors limit the length of thedye cell 505 to approximately one inch in length. - FIG. 7 shows a third embodiment based upon a modification of the second embodiment of FIG. 6. Here, a plurality of
dye input ports dye cell 605. Aninput manifold 625 of the circulator supplies dye to each of these ports from a pump 650.Output ports dye cell 105. Anoutput manifold 632 collects dye solution exiting thedye cell 605 through these ports. In this configuration, dye flowing through any one of the input ports 610-614 is divided and passes out both of the nearest output ports 620-624, again flowing parallel to thelaser axis 630. If the longitudinal distance between an input port and the closest output port is approximately 25 mm, 50 mm between adjacent input ports, a flow velocity of 10 m/sec is sufficient to limit the residence time of the dye solution to 2.5 msec. This allows the dye solution to be interchanged twice in a 5 msec laser pulse duration or four times in a 10 msec pulse. - Dye Lasers having a transverse flow of dye gain media through the resonant cavity have been developed in the past in a number of different contexts for different applications. Continuous wave (cw) dye lasers have even been developed. The dye in these lasers is pumped by another laser. This laser is focused on a small spot on a curtain of the flowing dye solution. Thus, volume of dye excited in this device is very small. Only the small portion of the dye curtain in the path of the beam from the focused pumping laser is excited, and therefore generates light by stimulated emission. Even though this type of laser-excited dye laser generates a continuous wave output, it can not produce the kilowatts of peak power with the energy content required by medical applications.
- Very high pulse rate transverse flow dye lasers have been developed for isotope separation applications. The intent of these designs is to produce output energies of approximately one Joule in a few microseconds. Thermal distortion, which limited firing rates were avoided by replacing the excited dye in the resonant cavity from a previous pulse with new dye and then triggering the flashlamp. Such devices have been shown to generate pulse frequencies of almost one kilohertz. In these industrial applications, the peak and average output powers and pulse frequencies far exceed those required for medical procedures where longer pulse durations, moderate peak and average powers at lower frequencies are preferred. Average power close to a kilowatt have been generated using transverse flow dye lasers. For medical application, average power of only a few Watts is required.
- While this invention has been particularly shown and described with references to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention encompassed by the appended claims.
Claims (18)
1. A method of treating simple wrinkles caused by age or sun exposure comprising treating blood vessels in the wrinkles with laser light.
2. The method as claimed in claim 1 , wherein the laser light has a wavelength between 577 and 585 nm.
3. The method as claimed in claim 1 , wherein the laser light comprises a laser light pulse having a duration greater than 0.2 msec.
4. The method as claimed in claim 1 , wherein the laser light comprises a laser light pulse having a duration greater than 0.5 msec.
5. The method as claimed in claim 1 , wherein the laser light is generated with a dye laser.
6. A method of treating simple wrinkles caused by age or sun exposure comprising the steps of:
generating a laser light output pulse having a wavelength in a range of 577 to 585 nm; and
delivering the laser light output pulse to the wrinkle-bearing skin of a patient.
7. The method as claimed in claim 6 , wherein the laser light output pulse has a pulse duration that is greater than 0.2 msec.
8. The method as claimed in claim 6 , wherein the laser light output pulse has a pulse duration that is greater than 0.5 msec.
9. The method as claimed in claim 6 , wherein the laser light output pulse is generated with a dye laser.
10. A method of treating simple wrinkles caused by age or sun exposure comprising the steps of:
generating a dye laser light output pulse; and
delivering the dye laser light output pulse to the wrinkle-bearing skin of a patient.
11. The method as claimed in claim 10 , wherein the step of generating a dye laser light output pulse comprises:
exciting dye solution in a resonant cavity to produce output laser light.
12. The method as claimed in claim 11 , wherein the dye solution is excited by at least one flashlamp.
13. The method as claimed in claim 11 additionally comprising the step of:
circulating dye solution through the resonant cavity during the generation of the laser light output pulse.
14. The method as claimed in claim 10 , wherein the dye laser output pulse has a pulse duration that is greater than 0.2 msec.
15. The method as claimed in claim 10 , wherein the dye laser output pulse has a pulse duration that is greater than 0.5 msec.
16. A laser treatment method for simple wrinkles caused by age or sun exposure, the method comprising irradiating wrinkle-bearing skin with a laser light output pulse having a pulse duration that is selectively matched to a thermal relaxation time of blood vessels in the targeted skin.
17. The method as claimed in claim 16 , wherein the pulse duration is greater than 0.2 msec.
18. The method as claimed in claim 16 , wherein the pulse duration is greater than 0.5 msec.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/010,872 US20020049433A1 (en) | 1995-06-05 | 2001-12-07 | Laser treatment of wrinkles |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/461,952 US5624435A (en) | 1995-06-05 | 1995-06-05 | Ultra-long flashlamp-excited pulse dye laser for therapy and method therefor |
US82244897A | 1997-03-21 | 1997-03-21 | |
US09/797,124 US20010009998A1 (en) | 1995-06-05 | 2001-03-01 | Laser treatment of wrinkles |
US10/010,872 US20020049433A1 (en) | 1995-06-05 | 2001-12-07 | Laser treatment of wrinkles |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/797,124 Continuation US20010009998A1 (en) | 1995-06-05 | 2001-03-01 | Laser treatment of wrinkles |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020049433A1 true US20020049433A1 (en) | 2002-04-25 |
Family
ID=23834596
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/461,952 Expired - Lifetime US5624435A (en) | 1995-06-05 | 1995-06-05 | Ultra-long flashlamp-excited pulse dye laser for therapy and method therefor |
US09/797,124 Abandoned US20010009998A1 (en) | 1995-06-05 | 2001-03-01 | Laser treatment of wrinkles |
US10/010,872 Abandoned US20020049433A1 (en) | 1995-06-05 | 2001-12-07 | Laser treatment of wrinkles |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/461,952 Expired - Lifetime US5624435A (en) | 1995-06-05 | 1995-06-05 | Ultra-long flashlamp-excited pulse dye laser for therapy and method therefor |
US09/797,124 Abandoned US20010009998A1 (en) | 1995-06-05 | 2001-03-01 | Laser treatment of wrinkles |
Country Status (11)
Country | Link |
---|---|
US (3) | US5624435A (en) |
EP (1) | EP0830719B1 (en) |
JP (1) | JPH11507180A (en) |
KR (1) | KR100416449B1 (en) |
AT (1) | ATE183855T1 (en) |
CA (1) | CA2222990A1 (en) |
DE (1) | DE69603960T2 (en) |
ES (1) | ES2137699T3 (en) |
IL (1) | IL122382A (en) |
TW (1) | TW342339B (en) |
WO (1) | WO1996039734A1 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030199866A1 (en) * | 1996-01-05 | 2003-10-23 | Stern Roger A. | Method and kit for treatment of tissue |
US20030216728A1 (en) * | 1996-01-05 | 2003-11-20 | Stern Roger A. | RF electrode assembly for handpiece |
US20040000316A1 (en) * | 1996-01-05 | 2004-01-01 | Knowlton Edward W. | Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient |
US20040002705A1 (en) * | 1996-01-05 | 2004-01-01 | Knowlton Edward W. | Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient |
US20040030332A1 (en) * | 1996-01-05 | 2004-02-12 | Knowlton Edward W. | Handpiece with electrode and non-volatile memory |
US20040111087A1 (en) * | 1999-03-09 | 2004-06-10 | Stern Roger A. | Handpiece for treatment of tissue |
US20070179480A1 (en) * | 2004-06-21 | 2007-08-02 | Doron Nevo | Dermatological laser system |
US20090088822A1 (en) * | 2007-09-27 | 2009-04-02 | Led Healing Light, Llc | Therapeutic pulse laser methods and apparatus |
US20090275928A1 (en) * | 2008-05-01 | 2009-11-05 | Solomon Mark P | Suture-less laser blepharoplasty with skin tightening |
US8613741B1 (en) * | 2006-10-11 | 2013-12-24 | Candela Corporation | Voltage bucking circuit for driving flashlamp-pumped lasers for treating skin |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5871479A (en) | 1996-11-07 | 1999-02-16 | Cynosure, Inc. | Alexandrite laser system for hair removal and method therefor |
US6547781B1 (en) * | 1996-04-09 | 2003-04-15 | Cynsure, Inc. | Ultra-long flashlamp-excited pulse dye laser for therapy and method therefor |
GB9618051D0 (en) * | 1996-08-29 | 1996-10-09 | Sls Wales Ltd | Wrinkle removal |
US5968034A (en) * | 1997-06-24 | 1999-10-19 | Laser Aesthetics, Inc. | Pulsed filament lamp for dermatological treatment |
US5885274A (en) * | 1997-06-24 | 1999-03-23 | New Star Lasers, Inc. | Filament lamp for dermatological treatment |
US7232456B2 (en) * | 1997-10-17 | 2007-06-19 | Chernoff W Gregory | Tissue treatment method |
US6077294A (en) * | 1998-06-11 | 2000-06-20 | Cynosure, Inc. | Method for non-invasive wrinkle removal and skin treatment |
US7049110B2 (en) * | 1998-07-21 | 2006-05-23 | Gambro, Inc. | Inactivation of West Nile virus and malaria using photosensitizers |
US6258577B1 (en) | 1998-07-21 | 2001-07-10 | Gambro, Inc. | Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers |
US20070099170A1 (en) * | 1998-07-21 | 2007-05-03 | Navigant Biotechnologies, Inc. | Method for treatment and storage of blood and blood products using endogenous alloxazines and acetate |
US6101207A (en) * | 1998-08-25 | 2000-08-08 | Ilorinne; Toni | Dye laser |
US6059820A (en) | 1998-10-16 | 2000-05-09 | Paradigm Medical Corporation | Tissue cooling rod for laser surgery |
US6451007B1 (en) * | 1999-07-29 | 2002-09-17 | Dale E. Koop | Thermal quenching of tissue |
US6268120B1 (en) | 1999-10-19 | 2001-07-31 | Gambro, Inc. | Isoalloxazine derivatives to neutralize biological contaminants |
US6364872B1 (en) * | 1999-12-06 | 2002-04-02 | Candela Corporation | Multipulse dye laser |
US6552301B2 (en) * | 2000-01-25 | 2003-04-22 | Peter R. Herman | Burst-ultrafast laser machining method |
US6436094B1 (en) | 2000-03-16 | 2002-08-20 | Laserscope, Inc. | Electromagnetic and laser treatment and cooling device |
US6554825B1 (en) | 2000-05-09 | 2003-04-29 | Laserscope | Variable pulse duration, adjustable wavelength medical laser system |
TW590780B (en) * | 2000-06-02 | 2004-06-11 | Gambro Inc | Additive solutions containing riboflavin |
US7648699B2 (en) * | 2000-06-02 | 2010-01-19 | Caridianbct Biotechnologies, Llc | Preventing transfusion related complications in a recipient of a blood transfusion |
US7985588B2 (en) * | 2000-06-02 | 2011-07-26 | Caridianbct Biotechnologies, Llc | Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light |
US9044523B2 (en) | 2000-06-15 | 2015-06-02 | Terumo Bct, Inc. | Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light |
US6843961B2 (en) | 2000-06-15 | 2005-01-18 | Gambro, Inc. | Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light |
GB2368020A (en) * | 2000-10-18 | 2002-04-24 | Icn Photonics Ltd | Treatment of acne vulgaris skin condition by irradiation with light of specific wavelengths to target specific chromophores & stimulate collagen production |
EP1337849B1 (en) * | 2000-11-30 | 2009-11-18 | Boston Probes, Inc. | Methods and compositions for sorting and/or determining microorganisms |
GB2370229A (en) * | 2000-12-22 | 2002-06-26 | Icn Photonics Ltd | Light delivery system for improving the appearance of skin |
JP2005535370A (en) | 2002-06-19 | 2005-11-24 | パロマー・メディカル・テクノロジーズ・インコーポレイテッド | Method and apparatus for treating skin and subcutaneous conditions |
US7413567B2 (en) * | 2003-02-25 | 2008-08-19 | Spectragenics, Inc. | Optical sensor and method for identifying the presence of skin |
US20100069898A1 (en) * | 2003-02-25 | 2010-03-18 | Tria Beauty, Inc. | Acne Treatment Method, System and Device |
EP1596747B1 (en) * | 2003-02-25 | 2016-02-17 | Tria Beauty, Inc. | Eye-safe dermatologic treatment apparatus |
US7981111B2 (en) | 2003-02-25 | 2011-07-19 | Tria Beauty, Inc. | Method and apparatus for the treatment of benign pigmented lesions |
JP2006518614A (en) * | 2003-02-25 | 2006-08-17 | スペクトラジェニクス インコーポレイテッド | Acne treatment apparatus and method |
ES2570985T3 (en) | 2003-02-25 | 2016-05-23 | Tria Beauty Inc | Apparatus and procedure for inhibiting new hair growth, safe for the eye and autonomous |
JP4361082B2 (en) * | 2003-02-25 | 2009-11-11 | トリア ビューティ インコーポレイテッド | Built-in diode laser dermatological treatment device |
EP2604215B1 (en) | 2003-02-25 | 2017-10-11 | Tria Beauty, Inc. | Eye-safe dermatologic treatment apparatus and method |
US8709003B2 (en) * | 2003-02-25 | 2014-04-29 | Tria Beauty, Inc. | Capacitive sensing method and device for detecting skin |
WO2004078034A2 (en) * | 2003-03-04 | 2004-09-16 | Spectragenics, Inc. | Method and apparatus for the repigmentation of human skin |
WO2004080279A2 (en) * | 2003-03-06 | 2004-09-23 | Spectragenics, Inc. | In the patent cooperation treaty application for patent |
US8777935B2 (en) * | 2004-02-25 | 2014-07-15 | Tria Beauty, Inc. | Optical sensor and method for identifying the presence of skin |
US7427289B2 (en) * | 2005-01-14 | 2008-09-23 | Cynosure, Inc. | Multiple wavelength laser workstation |
US7856985B2 (en) | 2005-04-22 | 2010-12-28 | Cynosure, Inc. | Method of treatment body tissue using a non-uniform laser beam |
US7586957B2 (en) | 2006-08-02 | 2009-09-08 | Cynosure, Inc | Picosecond laser apparatus and methods for its operation and use |
JP5628792B2 (en) * | 2008-04-25 | 2014-11-19 | トリア ビューティ インコーポレイテッド | Optical sensor and method for distinguishing skin presence and skin pigmentation |
US8717194B2 (en) | 2010-12-21 | 2014-05-06 | GE Lighting Solutions, LLC | LED traffic signal compensation and protection methods |
KR102183581B1 (en) | 2012-04-18 | 2020-11-27 | 싸이노슈어, 엘엘씨 | Picosecond laser apparatus and methods for treating target tissues with same |
EP3751684A1 (en) | 2013-03-15 | 2020-12-16 | Cynosure, Inc. | Picosecond optical radiation systems and methods of use |
WO2019165426A1 (en) | 2018-02-26 | 2019-08-29 | Cynosure, Inc. | Q-switched cavity dumped sub-nanosecond laser |
WO2023220248A1 (en) * | 2022-05-13 | 2023-11-16 | Cold Laser Therapeutics, Llc | Switchable low pulse rate and high pulse rate laser driver |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3766488A (en) * | 1971-06-17 | 1973-10-16 | Bell Telephone Labor Inc | Dye laser with pump cavity mode matched to laser resonator |
US4292601A (en) * | 1977-06-29 | 1981-09-29 | Jersey Nuclear-Avco Isotopes, Inc. | Flashlamp excited fluid laser amplifier |
JPS62500626A (en) * | 1984-10-25 | 1987-03-12 | キャンデラ・レ−ザ−・コ−ポレ−ション | Method and apparatus for amplifying light to generate a pulsed output beam of light |
US4862886A (en) * | 1985-05-08 | 1989-09-05 | Summit Technology Inc. | Laser angioplasty |
US5092865A (en) * | 1987-02-27 | 1992-03-03 | Xintec Corporation | Optical fiber fault detector |
US5057099A (en) * | 1987-02-27 | 1991-10-15 | Xintec Corporation | Method for laser surgery |
US4822600A (en) * | 1987-05-27 | 1989-04-18 | Neutrogena Corporation | Infrared blocker |
US4977571A (en) * | 1988-03-29 | 1990-12-11 | Candela Laser Corporation | Dye laser solution circulation system |
US5180378A (en) * | 1989-04-24 | 1993-01-19 | Abiomed, Inc. | Laser surgery system |
US5109387A (en) * | 1990-12-26 | 1992-04-28 | Garden Jerome M | Dye laser system and method |
US5287380A (en) * | 1993-02-19 | 1994-02-15 | Candela Laser Corporation | Method and apparatus for generating long output pulses from flashlamp-excited lasers |
US5387211B1 (en) * | 1993-03-10 | 1996-12-31 | Trimedyne Inc | Multi-head laser assembly |
US5668824A (en) * | 1993-07-28 | 1997-09-16 | Cynosure, Inc. | Method and apparatus for replenishing dye solution in a dye laser |
FR2729854A1 (en) * | 1995-01-26 | 1996-08-02 | Oreal | USE OF DEHYDROEPI-ANDROSTERONE SULFATE IN A COSMETIC OR DERMATOLOGICAL COMPOSITION |
-
1995
- 1995-06-05 US US08/461,952 patent/US5624435A/en not_active Expired - Lifetime
-
1996
- 1996-06-01 TW TW085106589A patent/TW342339B/en active
- 1996-06-03 EP EP96916932A patent/EP0830719B1/en not_active Expired - Lifetime
- 1996-06-03 IL IL12238296A patent/IL122382A/en not_active IP Right Cessation
- 1996-06-03 JP JP9500946A patent/JPH11507180A/en not_active Ceased
- 1996-06-03 WO PCT/US1996/008301 patent/WO1996039734A1/en active IP Right Grant
- 1996-06-03 CA CA002222990A patent/CA2222990A1/en not_active Abandoned
- 1996-06-03 ES ES96916932T patent/ES2137699T3/en not_active Expired - Lifetime
- 1996-06-03 DE DE69603960T patent/DE69603960T2/en not_active Expired - Lifetime
- 1996-06-03 KR KR1019970708751A patent/KR100416449B1/en not_active IP Right Cessation
- 1996-06-03 AT AT96916932T patent/ATE183855T1/en not_active IP Right Cessation
-
2001
- 2001-03-01 US US09/797,124 patent/US20010009998A1/en not_active Abandoned
- 2001-12-07 US US10/010,872 patent/US20020049433A1/en not_active Abandoned
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030199866A1 (en) * | 1996-01-05 | 2003-10-23 | Stern Roger A. | Method and kit for treatment of tissue |
US20030216728A1 (en) * | 1996-01-05 | 2003-11-20 | Stern Roger A. | RF electrode assembly for handpiece |
US20040000316A1 (en) * | 1996-01-05 | 2004-01-01 | Knowlton Edward W. | Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient |
US20040002705A1 (en) * | 1996-01-05 | 2004-01-01 | Knowlton Edward W. | Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient |
US20040030332A1 (en) * | 1996-01-05 | 2004-02-12 | Knowlton Edward W. | Handpiece with electrode and non-volatile memory |
US20040111087A1 (en) * | 1999-03-09 | 2004-06-10 | Stern Roger A. | Handpiece for treatment of tissue |
US20070179480A1 (en) * | 2004-06-21 | 2007-08-02 | Doron Nevo | Dermatological laser system |
US9161815B2 (en) | 2004-06-21 | 2015-10-20 | Kilolambda Technologies Ltd. | Dermatological laser system and Method for Skin Resurfacing |
US8613741B1 (en) * | 2006-10-11 | 2013-12-24 | Candela Corporation | Voltage bucking circuit for driving flashlamp-pumped lasers for treating skin |
US20090088822A1 (en) * | 2007-09-27 | 2009-04-02 | Led Healing Light, Llc | Therapeutic pulse laser methods and apparatus |
US20090275928A1 (en) * | 2008-05-01 | 2009-11-05 | Solomon Mark P | Suture-less laser blepharoplasty with skin tightening |
Also Published As
Publication number | Publication date |
---|---|
IL122382A0 (en) | 1998-06-15 |
KR19990022272A (en) | 1999-03-25 |
JPH11507180A (en) | 1999-06-22 |
WO1996039734A1 (en) | 1996-12-12 |
EP0830719A1 (en) | 1998-03-25 |
ATE183855T1 (en) | 1999-09-15 |
TW342339B (en) | 1998-10-11 |
EP0830719B1 (en) | 1999-08-25 |
DE69603960T2 (en) | 2000-01-27 |
DE69603960D1 (en) | 1999-09-30 |
ES2137699T3 (en) | 1999-12-16 |
IL122382A (en) | 2002-03-10 |
CA2222990A1 (en) | 1996-12-12 |
US5624435A (en) | 1997-04-29 |
KR100416449B1 (en) | 2004-03-19 |
US20010009998A1 (en) | 2001-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5624435A (en) | Ultra-long flashlamp-excited pulse dye laser for therapy and method therefor | |
US6610052B2 (en) | Laser system and method for treatment of biologic targets | |
US5871479A (en) | Alexandrite laser system for hair removal and method therefor | |
KR101252882B1 (en) | Multiple Wavelength Laser Workstation | |
US5558667A (en) | Method and apparatus for treating vascular lesions | |
US5749868A (en) | Near infra-red selective photothermolysis for ectatic vessels and method therefor | |
US5598426A (en) | Method and dye laser apparatus for producing long pulses of laser radiation | |
US6547781B1 (en) | Ultra-long flashlamp-excited pulse dye laser for therapy and method therefor | |
US6364872B1 (en) | Multipulse dye laser | |
US20030069617A1 (en) | Method of corneal scuplting using a laser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |